- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy high growth potential
South Korean Pharmaceuticals & Biotech Healthy high growth potential
Results
5
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
5 companies
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,400.00
7D
8.1%
1Y
18.7%
HansBiomed
Market Cap: ₩345.1b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩24,200.00
7D
19.5%
1Y
182.7%
ALTEOGEN
Market Cap: ₩22.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩327,500.00
7D
22.7%
1Y
-2.0%
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩417,000.00
7D
8.5%
1Y
-37.7%
DreamCIS
Market Cap: ₩87.9b
Operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada.
A223250
₩3,575.00
7D
9.7%
1Y
1.4%